NCT06899984Active, not recruiting
Using Technology to Address Disparities and Promote Healthcare Equity in Type 1 Diabetes Registry
Source: ClinicalTrials.gov · Last updated 24 Nov 2025
Brief summary (registry, in English)
This study is being done to see if using technology, with the help of a Patient Navigator, can help address disparities, improve outcomes, and promote healthcare equity in type 1 diabetes.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- First submitted
- 11 Mar 2025
- Start date
- 20 Nov 2020
- Primary completion date
- Oct 2026
- Lead sponsor
- University of Chicago
- Diseases
- Type 1 diabetes
- NCT number
- NCT06899984
What you commit to
- Study type: Interventional
- Planned participants: 150
- From 20 Nov 2020 to the primary completion date, Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Inability or unwillingness to share CGMS data with the study team
Who the study is looking for
- Males or females age 14 to 64 years
- Clinical diagnosis of type 1 diabetes (T1D)
- Two or more hospitalizations with diabetic ketoacidosis (DKA) within the past 5 years or hemoglobin A1c greater than 10% on two or more laboratory samples in the last 2 years.
- Informed Consent
- Has a CGMS or a prescription for a CGMS as part of their clinical care as part of their clinical care
Age in the registry: 14 years to 64 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Chicago Coordinator of this site? Confirm its status | Chicago | United States | Unknown status |
Related publications
- Using technology to address disparities and promote healthcare equity in Type 1 Diabetes (EquiT1D) A nonrandomized clinical trial investigating solutions to low technology use.J Clin Transl Endocrinol · 2026 · PMID 42633177
This page is information, not medical advice. Discuss any trial with your doctor.